首页> 外文期刊>Progress in Neuro-Psychopharmacology & Biological Psychiatry: An International Research, Review and News Journal >The neurobiology of neurodegenerative disorder: from basic to clinical research. Preface.
【24h】

The neurobiology of neurodegenerative disorder: from basic to clinical research. Preface.

机译:神经退行性疾病的神经生物学:从基础到临床研究。前言。

获取原文
获取原文并翻译 | 示例
       

摘要

Despite intensive research, the etiology, pathophysiology and molecular basis of neurodegenerative disorders like Alzheimer's disease (AD), Parkinson's disease (PD) and amyloid lateral sclerosis (ALS) are far from clear. The reason the results of preclinical studies do not translate to patients with a neurodegenerative disorder could be a lack of suitable animal models. Since neurodegenerative disorders are complex and progressive, there is no animal model that could replicate entire pathology and symptomatology of the diseases. The lack of effective medications is an additional problem in everyday practice. The treatment with available medications achieves only transient improvement in symptoms and is unable to stop the progress of AD, PD or ALS. The efficacy of new potential drugs is disappointing, probably due to an inappropriate drug target.
机译:尽管进行了深入研究,但神经退行性疾病(如阿尔茨海默氏病(AD),帕金森氏病(PD)和淀粉样侧索硬化症(ALS))的病因,病理生理和分子基础尚不清楚。临床前研究结果不能转化为神经退行性疾病患者的原因可能是缺乏合适的动物模型。由于神经退行性疾病是复杂的和进行性的,因此没有动物模型能够复制疾病的整个病理和症状。缺乏有效药物是日常实践中的另一个问题。使用可用药物进行的治疗只能实现症状的暂时改善,并且无法阻止AD,PD或ALS的进展。新的潜在药物的疗效令人失望,这可能是由于药物目标不当所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号